Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Bolt Biotherapeutics, Inc. (BOLT) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Bolt Biotherapeutics, Inc. (BOLT), most recent 12 months reported: revenue $4.7M, net loss $28.74M, free cash flow -$39.92M. Latest balance sheet on file: liquid cash $17.6M. From SEC filings. Others in Pharmaceutical Preparations: Alumis Inc. · NewAmsterdam Pharma Company N.V. · HCW Biologics Inc. · RANI THERAPEUTICS HOLDINGS, INC. · ENTRADA THERAPEUTICS, INC. · KYNTRA BIO, INC. · Ensysce Biosciences, Inc. · CAMP4 Therapeutics Corporation

Stock screener

Watchlist